DRCT vs REVB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

DRCT

40.3
AI Score
VS
DRCT Wins

REVB

33.8
AI Score

Investment Advisor Scores

DRCT

40score
Recommendation
HOLD

REVB

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric DRCT REVB Winner
Net Income -18.95M -6.33M REVB
Operating Income -14.76M -6.75M REVB
ROE 269.8% -62.9% DRCT
ROA -94.0% -50.7% REVB
Total Assets 20.16M 12.50M DRCT
Cash 728,000 11.48M REVB
Current Ratio 0.18 6.21 REVB

Relative Price Performance (Last 90 Days)

DRCT 1M: -52.4% · 3M: -67.0% REVB 1M: +335.5% · 3M: +257.5%

Current Technical Phase

DRCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.4%), weak momentum, RSI 18

RSI (14): 17.9 · Price: $0.91

REVB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.4% over 20 days), RSI 86

RSI (14): 85.5 · Price: $3.79

Fundamentals Snapshot

Metric DRCT REVB
Market Cap — —
Forward P/E -0.1 -0.2
Trailing P/E — 0.1
Revenue (TTM) — —
Revenue Growth -0.2% 0.0%
Gross Margin 0.3% —
Operating Margin -0.4% 0.0%
EPS -197.09 32.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, DRCT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.